ArticleChemistry & biodiversity2026
Chemical Profile, Anti-Inflammatory, and Antioxidant Potential of Hydroalcoholic Extracts and Fractions From Baccharis glaziovii Baker (Asteraceae).
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanisms and Therapeutic Targets of Botanicals Derived from Asteraceae Plant Species.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Baccharis glaziovii Baker, known as carqueja-arbustinho, is a native Brazilian plant characterized by its three-winged stems. This study investigated the chemical profile and biological potential of hydroalcoholic extracts and fractions from male and female specimens. Chemical characterization by nuclear magnetic resonance and mass spectrometry indicated a phenolic profile, with the flavonoid apigenin identified in the dichloromethane fraction of both extracts. Anti-inflammatory activity was assessed by the inhibition of bovine serum albumin (BSA) denaturation, with the female and male extracts showing inhibition of 64.1% and 62.2%, respectively, compared to 84.3% for sodium diclofenac. The highest effect was observed at 400 µg mL
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.